MERCK KGAA O.N./ DE0006599905 /
2024-03-28 11:54:23 AM | Chg. +5.15 | Volume | Bid8:44:03 PM | Ask8:44:03 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
163.90EUR | +3.24% | 5 Turnover: 819.50 |
-Bid Size: - | -Ask Size: - | 21.05 bill.EUR | 1.35% | 25.10 |
GlobeNewswire
2:00 PM
Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire
11:00 AM
Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA